Press Release |
|
| MEDIA ADVISORY: Wednesday, July 27, 2005 |
CONTACT: Alison Kogut 202–395–5744 |
WHITE HOUSE ANNOUNCES INTENT TO NOMINATE BERTHA MADRAS AS DEPUTY DIRECTOR FOR DEMAND REDUCTION AT THE OFFICE OF NATIONAL DRUG CONTROL POLICY
(Washington, D.C.)—Today, the White House announced the President's intention to nominate Bertha Madras, PhD as the Deputy Director for Demand Reduction in the Office of National Drug Control Policy. The Office of Demand Reduction oversees the implementation of the President's prevention and treatment policy, including programs such as Access to Recovery (ATR), Student Drug Testing, and Screening Brief Intervention Referral and Treatment (SBIRT).
John P. Walters, Director of National Drug Control Policy, said, "Dr. Madras brings a wealth of knowledge to ONDCP through her extensive work as a researcher and professor. Her commitment to studying the disease of drug addiction and substance abuse will be a great help to our work at ONDCP. I am eager for Dr. Madras to join the Administration's anti-drug efforts, where we can make use of her expertise to enhance and aid the work of prevention and treatment efforts throughout the country. We look forward to working with Members of Congress for her swift confirmation."
Dr. Madras currently is a professor of Psychobiology in the Department of Psychiatry at Harvard Medical School and chairs the Division of Neurochemistry at the New England Primate Research Center. In addition to her current positions, Dr. Madras serves on several National and government advisory boards including, the Molecular Neuropharmacology and Signaling Review Committee on the National Institutes of Health and the Medications Development Scientific Advisory Board at the National Institute of Drug Abuse. Furthermore, Dr. Madras has traveled the United States and abroad presenting prevention lectures on how drugs affect the brain and is currently conducting research on cocaine, ecstasy, and cannabinoids.
